ISB News

ISB K-12 Science Education Team Helps ‘STEM’ School Develop Curriculum

Riverpoint Academy in Spokane has been working with ISB’s K-12 science education team to develop curriculum that falls under “STEM” – science, technology, engineering and math. Riverpoint describes itself as a STEM school that also teaches arts, humanities and entrepreneurship. Some educators and administrators from Riverpoint and the Mead School District, as well as other community leaders visited ISB on May 3 and 4 to participate in a workshop to discuss how a signature project could be developed around personalized health. On May 21, students from Riverpoint Academy attended a panel featuring ISB scientists and then took a tour of the high-tech facilities. In April, Dr. Lee Hood, ISB president, traveled to Spokane to visit with students in the Mead District, including at Riverpoint Academy. Read the Spokesman Review’s story about the visit.

Recent Articles

  • Timing is Everything: ISB Study Finds Link Between Bowel Movement Frequency and Overall Health

    Everybody poops, but not every day. An ISB-led research team examined the clinical, lifestyle, and multi-omic data of more than 1,400 healthy adults. How often people poop, they found, can have a large influence on one’s physiology and health.

  • Wei Wei, PhD

    Dr. Wei Wei Promoted to Associate Professor

    Wei Wei, PhD – an accomplished cancer researcher with expertise in biotechnology and cancer systems biology – has been promoted to ISB associate professor. The Wei Lab focuses on understanding how cancer cells adapt to therapeutic treatment to foster therapy resistance by coordinating their internal molecular machinery and how these adaptive changes evolve within diverse tumors influenced by the tumor microenvironment. 

  • Drs. Nitin Baliga and James Park

    How Glioblastoma Resists Treatment – and Ways to Prevent It

    Glioblastoma is one of the deadliest and most aggressive forms of primary brain cancer in adults and is known for its ability to resist treatment and to recur. ISB researchers have made breakthrough discoveries in understanding the mechanisms behind acquired resistance, focusing on a rare and stubborn group of cells within tumors called glioma stem-like cells.